Innovent Biologics Inc.
IVBXF | OTC
$9.90
-$1.40 (-12.39%)
At close: Oct 30, 2026, 2:35 PM ET
$9.90
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 4:00 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 142.68 | -591.65 | -58.69 | -20.26 | -20.90 | -94.13 |
PEG Ratio | -0.15 | 6.49 | 1.07 | 0.91 | -0.14 | 1.85 |
PS Ratio | 9.09 | 5.94 | 9.73 | 9.67 | 13.36 | 24.45 |
PB Ratio | 6.12 | 4.26 | 4.82 | 4.11 | 5.52 | 10.70 |
P/FCF Ratio | 12.72 | -133.71 | -48.89 | -13.35 | -14.73 | -87.07 |
P/OCF Ratio | 11.85 | 43.47 | 408.73 | -22.97 | -28.17 | -305.46 |
OCF/S Ratio | 76.69 | 13.66 | 2.38 | -42.11 | -47.42 | -8 |
Debt / Equity Ratio | 0.15 | 0.22 | 0.29 | 0.30 | 0.24 | 0.14 |
Quick Ratio | 2.47 | 2.16 | 2.78 | 2.88 | 3.35 | 5.90 |
Current Ratio | 2.62 | 2.35 | 3 | 3.29 | 3.79 | 6.37 |
Asset Turnover | 0.35 | 0.44 | 0.30 | 0.26 | 0.26 | 0.32 |
Interest Coverage | 9.46 | -11.17 | -17.03 | -30.71 | -43.28 | -8.15 |
Return on Equity | 4.20% | -0.72% | -8.21% | -20.31% | -26.41% | -11.37% |
Return on Assets | 2.18% | -0.44% | -4.98% | -12.39% | -16.80% | -8.44% |
Return on Invested Capital | 2.39% | -4.28% | -8.68% | -20.81% | -19.91% | -5.25% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 76.66% | 83.97% | 70.89% | 79.57% | 86.58% | 89.91% |
Net Profit Margin | 6.24% | -1% | -16.56% | -47.83% | -63.91% | -25.97% |
Pretax Profit Margin | 6.43% | -0.83% | -18.44% | -47.64% | -61.87% | -22.34% |
Operating Profit Margin | 5.63% | -8.02% | -27.06% | -68.54% | -63.31% | -14.50% |
FCF Margin | 71.45% | -4.44% | -19.91% | -72.44% | -90.69% | -28.08% |
EBITDA Margin | 10.05% | -5.10% | -10.65% | -38.39% | -55.61% | -18.33% |
Add to Watchlist
Select watchlists to add or remove IVBXF